accountFood and Drug Administration already has approved several NMDA receptor inhibitors, including the cough suppressant...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ALZHEIMER'S
Given that 26 million people worldwide have Alzheimer's disease and 106 million could be afflicted by 2050, any treatment that alters the course of the disease will become a multi-billion-dollar drug. Major pharmaceutical companies and biotech startups are racing to develop the first drugs to delay or reverse Alzheimer’s. Medical device makers are also developing screening tests to more accurately diagnose Alzheimer’s, and health care providers are trying to find ways to better manage patients.
Alzheimer's is part of Business Exchange, suggested by
Cathy Arnst.
This topic contains
1,245 news
and
1,151 blog
items.
Read updated news, blogs, and resources about Alzheimer's. Find user-submitted articles and reactions on Alzheimer's from
like-minded professionals.
News
Please add new articles to this topic
Is Wyeth and Elan's Alzheimer's antibody better than it appears in Phase 2 clinical trial data?
An examination of Eli Lilly's early-stage Alzheimer's drug
Why so much excitement by the media over early-phase trials of a drug that targets TAU?
Intraday data provided by Interactive Data Real Time Services, a division of Interactive Data Corp. and subject to...
considerably higher than anticipated,' lead researcher Dr. Ronald C. Petersen said in a news release. 'If we...
and the first new drugs could hit the market in as soon as three years. 'The rate of Alzheimer's is going to explode as...
TauRX Therapeutics had just released what appeared to be spectacular data from Phase II clinical trials for their...
interests included health, welfare and social policy issues, patient-centred care, and services and informal care for...
that the Company's clinical stage drugs AL-108 and AL-208 penetrate the blood brain barrier of healthy adults and...
'hype' the drug. I reported that in a subset of patients there appeared to be what one leading Alzheimer's expert...
If so, an insulin-centered treatment could alter the course of the disease
After a century, promising treatments at last—and whispers of a cure
Mixed drug trial results at the International Conference on Alzheimer's Disease deflate Wall Street, but scientists...
in late trading Tuesday, after the pharmaceutical companies said a clinical study of the effectiveness of their...
The fourth instalment of the World News America series on Alzheimer's goes to South Korea, a country with the most...
slow, plodding scientific research and the demands of Wall Street are on stark display in the world of Alzheimer's drug...
analyst John Boris says he's downgrading Wyeth (WYE) shares to sell from hold as he removes the experimental...
percent to $81.2 million, chiefly reflecting Elan's efforts to produce treatments and a potential cure for the...
Extract not available.
Top Sources: Alzheimer's
- alzheimersreadingroom.com
- Reuters
- US News
- New York Times
- Boston Globe
- sciencedaily.com
- Mail Online UK
- Los Angeles Times
- rttnews.com
- MarketWatch
Post a Job
Jobs in this Topic
Life Guidance Director - Alzheimer's/ Memory Care Director
Atria Senior Living Group
|
Salisbury, MD
Posted: May 25
Volunteer Opportunity - Creative Arts Program
Alzheimer's Association Central & Western Virginia Chapter
|
Charlottesville, VA
Posted: Dec 15